等待開盤 11-18 09:30:00 美东时间
-0.020
-0.45%
Biotech ETFs are heading into a potentially pivotal week after missing last week’s broader market rally, with two closely watched FDA decisions, Alzheimer’s research updates and obesity-drug developments offering fresh catalysts for the sector. The SPDR S&P Biotech ETF (NYSE:XBI) fell 1.09% last wee...
11-16 22:23
今日重点评级关注:摩根大通:维持CytomX Therapeutics"超配"评级,目标价从11美元升至12美元;康托·菲茨杰拉德:维持Exodus Movement"超配"评级,目标价从15美元升至16美元
11-13 11:50
HC Wainwright & Co. analyst Matthew Caufield assumes Savara (NASDAQ:SVRA) with a Buy rating and announces Price Target of $10.
11-12 19:40
11月12日,Savara Inc(SVRA)收涨1.42%,报4.99美元,成交额4705.9万美元,市值11.01亿美元。 行情数据 • 开盘价:4.99美...
11-12 06:43
11月4日,Savara Inc(SVRA)收涨0.42%,报4.75美元,成交额1002.3万美元,市值9.76亿美元。 行情数据 • 开盘价:4.78美元...
11-04 06:44
10月28日,Savara Inc(SVRA)收涨7.52%,报4.86美元,成交额1724.8万美元,市值9.99亿美元。 行情数据 • 开盘价:4.49美元...
10-28 05:46
Savara Inc. (NASDAQ:SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the CHEST 2026 Annual Meeting in Phoenix, Arizona. The poster reports a post-hoc analysis of the IMPALA clinical trial evaluating the effects of molgramosti...
10-22 01:13
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-20 05:48
今日重点评级关注:DA Davidson:维持美光科技"买入"评级,目标价从2100美元升至3000美元;Leerink Partners:维持OmniAb"跑赢大市"评级,目标价从10美元升至12美元
10-08 12:30
U.S. stocks were lower, with the Dow Jones index falling around 1% on Wednesday. Shares of BKV Corp (NYSE:BKV) rose sharply after the company announced that a subsidiary executed into an equipment supply contract. BKV shares jumped 9.2% to $24.08 on Wednesday. Here are some other big stocks recordin...
10-07 22:08